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Case Report 
Surgical Treatment of Patients With Stenosis of 
the Central Airway due to Tracheal Tumours
Manabu Yasuda, Takeshi Hanagiri, Yoshinobu Ichiki, Hidetaka Uramoto, Mitsuhiro Takenoyama and 
Kosei Yasumoto, Second Department of Surgery, School of Medicine, University of Occupational and Environmental
Health, Japan, Kitakyushu, Japan.
This study retrospectively evaluated bronchoscopic and surgical treatments for patients with central air-
way stenosis due to tracheal tumours. Seven patients treated by resection and reconstruction of the tra-
chea for tracheal tumours between 1994 and 2008 were retrospectively reviewed. The most common
histological finding was thyroid carcinoma (n = 3), followed by adenoid cystic carcinoma (n = 2), a
metastatic thyroid tumour (n = 1), and a benign granular cell tumour (n = 1). Three of the patients
required preoperative laser treatment (Nd:YAG) for recanalization. Five patients underwent end-to-end
anastomosis for reconstruction. There was no postoperative mortality or morbidity such as anastomotic
insufficiency of the reconstructed trachea. Three patients with a microscopic residual tumour required
postoperative external radiotherapy. Surgical resection of malignant tracheal tumours is recommended
not only for curative purposes, but also for reduction of the risk of smothering. [Asian J Surg
2010;33(4):212–7]
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Introduction
Obstruction of the central airway due to tracheal tu-
mours is caused by intraluminal tumour growth, extralu-
minal tumour compression, or a combination of both.
Primary tracheal tumours are relatively rare neoplasms.
Grillo and Mathisen1 reported that tracheal tumours
account for only 2% of lung tumours. Therefore, their
clinical characteristics and surgical results have not been
thoroughly discussed.2,3 A variety of histological features
of tracheal tumours have been reported, including be-
nign, low-grade, and high-grade malignancies.4–6 Tracheal
tumours are sometimes misdiagnosed; airway obstruc-
tion is prone to be treated as asthma and eventually
becomes a life-threatening emergency.5,6 Tracheal involve-
ment of secondary tumours, such as cancers of the larynx,
thyroid, oesophagus, and lungs, is more common than that
of primary tumours.7,8 Even mediastinal lymph node en-
largement caused by metastasis or tuberculosis may lead
to considerable tracheal compression and life-threatening
suffocation.9 Lung cancer invading the distal trachea as
T4 tumours is the most common cause for resection of
the distal trachea, which is among the most challenging
types of surgery.10
The present study retrospectively reviewed seven cases
of tracheal tumours and describes the clinical features of
this rare disease. Furthermore, the therapeutic modalities
of the disease are discussed.
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Case reports
Seven patients with tracheal tumours were treated at this
institution between 1994 and 2008. The preoperative
evaluation included chest radiography, chest computed
tomography (CT), pulmonary function testing, and elec-
trocardiography. CT scanning or echosonography of the
abdomen, CT or magnetic resonance imaging of the
brain, and bone scintigraphy were routinely performed to
exclude distant metastasis. Bronchoscopy was always per-
formed preoperatively to assess any abnormalities and
evaluate the resection margin of the trachea.
The tracheal resections were performed via a right pos-
terolateral thoracotomy and were combined with a cervi-
cal approach for tumours in the upper part of the tracheal
section. The tracheal anastomoses were performed using
interrupted 3-0 braided absorbable sutures. An intraoper-
ative frozen section of the resection margin was routinely
obtained to confirm oncologic completeness. Postopera-
tive bronchoscopy was routinely performed to ensure the
success of the anastomosis at the end of the procedure.
Epidural anaesthesia was routinely used to reduce post-
operative pain and to enable the patients to clear respira-
tory secretions through improved coughing and deeper
inspiration.
Follow-up information was obtained from all patients
through office visits or telephone interviews with the
patient, with a relative, or with their primary physicians. The
patients were evaluated every month by chest radiography,
and bronchoscopy; systemic CT and bone scintigraphy
were performed every 6 months for 2 years after surgery
and annually thereafter. The mean follow-up period was
68.4 months.
Results
There were four males and three females whose ages
ranged from 30 to 65 years (mean, 52.6 years). One had a
benign tumour and six had malignant tumours. All
patients were symptomatic. Their symptoms included
dyspnoea (n = 3), haemoptysis (n = 2), coughing (n = 1),
and a cervical tumour (n = 1) (Table 1). Tracheal stenosis
was observed in each case by preoperative bronchoscopy.
The severity of the tracheal stenosis ranged from 20% to
90%. The tumours were located in the upper part of the
tracheal section in three patients (Cases 4, 5, and 7), and
in the middle part of the tracheal section in four patients
(Cases 1–3 and 6). The longitudinal spread of the tumour
was a median of 2.3 cm (range: 1.0–3.0 cm).
Preoperative endoscopic intervention was necessary in
three patients (Cases 1, 2, and 7) due to severe stenosis
(> 80%), and laser ablation (Nd:YAG) was performed to
maintain airway patency (Figure 1). Case 2 also under-
went bronchial arterial infusion (BAI) therapy with cis-
diamminedichloroplatinum (CDDP).10–12
The surgical procedures are summarized in Table 2. 
A right posterolateral thoracotomy was performed with mo-
bilization of the mediastinum and pericardial circumcision
Table 1. Seven patients with tracheal tumour10–12
Case Age Gender Symptom
Length of Severity Treatment 
Diagnosis
tumour (cm) of stenosis (%) before surgery
1 64 F Dyspnea 2.5 80 Nd-YAG laser Adenoid cystic 
carcinoma
2 41 M Dyspnea 3.0 80 Nd-YAG laser, BAI Adenoid cystic 
carcinoma
3 30 F Haemosputum 1.0 20 None Granular cell 
tumour
4 52 M Cough 3.0 50 None Thyroid cancer
5 55 F Haemosputum 3.0 50 None Thyroid cancer
6 61 M Cervical tumour 1.5 20 None Thyroid cancer 
(Lymph node 
metastasis)
7 65 M Dyspnea 2.0 90 Nd-YAG laser Metastatic thyroid 
tumour
BAI=bronchial arterial infusion therapy.10–12
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in all seven patients. Tracheal resection was performed via
the cervical approach in the cases with lesions in the upper
part (Cases 4, 5 and 7). The extent of the tracheal resec-
tion was a median of 2.8 cm (2.0–4.0 cm). Five patients
underwent an end-to-end anastomosis for reconstruc-
tion. A terminal tracheostomy was performed in Case 6
because he had undergone a laryngectomy for laryngeal
cancer. A partial tracheal resection was performed in 
Case 7 because of a metastatic renal tumour in the thyroid,
and it was covered with pericardium and thymic tissue.
Two cases (Cases 4 and 5) with thyroid cancer required
suprahyoid release of the larynx and thyroidectomy.
High-frequency jet ventilation was used during the anas-
tomoses in all patients.
All surgical margins were examined by frozen sections
during surgery to confirm the absence of tumour cells.
The pathological diagnoses included a malignant tumour
in six cases (three thyroid carcinomas, two adenoid cystic
carcinomas, and one metastatic renal carcinoma) and 
a benign tumour in one (granular cell tumour). Micro-
scopic tumour invasion at the resection margin was revealed
in a paraffin-embedded section in the cases with adenoid
cystic carcinoma (Cases 1 and 2), and in the case of a
metastatic renal tumour (Case 7).
There was no postoperative morbidity. No patients
experienced anastomotic leakage or stenosis. Four patients
experienced complications, which are listed in Table 2.
Two patients had pneumonia and one had mediastinitis.
One patient (Case 5) experienced dysphagia and required
tracheostomy and temporary gastrostomy. Postoperative
external radiotherapy was performed in three patients
(Table 2) because of microscopic residual tumour tissue
(Cases 1, 2 and 7). One patient (Case 4) with thyroid can-
cer underwent iodine-131 therapy.
The long-term results are summarized in Table 2. 
The median survival was 55 months for the six patients
who had a malignancy. Four patients died without local
recurrence. Three patients were still alive with no sign of
recurrence (one adenoid cystic carcinoma, one thyroid
carcinoma, and one benign tumour). The patients with
adenoid cystic carcinoma (n = 2) survived for 17–119
months after surgery. Case 1 had a local recurrence and
A B
C D
Before laser ablation After laser ablation
Before laser ablation After laser ablation
Figure 1. Effect of laser ablation for a tracheal tumour. (A, B) Adenoid cystic carcinoma (Case 1). (C, D) Metastatic thyroid tumour
(Case 7).
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was repeatedly treated with laser ablation. She died after
119 months because of distant metastasis to the liver.
Another patient (Case 2) underwent postoperative radio-
therapy because of a microscopic residual tumour and
maintained good health without local recurrence for 
2 years.
Discussion
There are a variety of primary tracheal tumours, including
benign, low-grade, and high-grade malignancies. Adenoid
cystic carcinomas, which most commonly develop in the
salivary glands, are also a common type of neoplasm in
the trachea. These tumours are generally regarded to have
low-grade malignant potential;13 however, they have 
a tendency for local recurrence and late development of
distant metastasis, as observed in Case 1. Surgical resection
is thought to be the first choice of treatment for localized
lesions. However, because tumours with a malignant
potential tend to infiltrate along the airways, they are
often treated with an incomplete resection and thus are
prone to recur locally (Cases 1 and 2). The complete resec-
tion rates in reported cases range from 42% to 57%. Pearson
et al14 reported that nine of 26 adenoid cystic carcinoma
surgeries resulted in an incomplete resection, and seven
of these nine patients died of local failure. Gaissert et al15
also reported that 59% of patients with resected adenoid
cystic carcinoma had positive airway margins. They noted
that the adenoid cystic carcinomas were longer and fre-
quently extended into the peritracheal soft tissues or to
adjacent organs. Despite the administration of preopera-
tive induction chemotherapy (BAI with CDDP) in the
current series, Case 2 had microscopic residual tumours
at the surgical margin. However, this patient did well
without local recurrence after the completion of postop-
erative radiotherapy. Local recurrence after surgery in
Case 1 was also controllable with radiotherapy and
repeated laser ablation. Tracheal involvement due to thy-
roid carcinoma was the most common neoplasm among
the secondary tumours in the current study (Cases 4–7).
The frequency of laryngotracheal invasion by thyroid can-
cer is approximately 7–10%.7,8 The management of locally
invasive thyroid carcinoma has been controversial. The
postoperative survival rate is much worse in patients
undergoing an incomplete resection than in those under-
going a complete resection of thyroid carcinoma.16,17
Therefore, a complete resection must always be attemptedTa
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whenever possible in thyroid carcinoma that secondarily
involves the trachea.
Induction therapies for tracheal tumours are not well
established because of their rarity. Induction radiother-
apy increases the risk for complications, such as failure of
anastomosis after surgery; thus, most of the current
patients were treated with radiotherapy after the surgical
resection (Cases 1, 2, and 7). There have been a few reports
about the safety of bronchoplasty procedures after preop-
erative chemotherapy.18–20 BAI is applied as an induction
therapy for locally advanced nonsmall cell lung cancer
(NSCLC)10,11 and as a radical therapy for hilar early
NSCLC.12 One of the advantages of BAI is that a high
dose of antitumour agents can be used for locally
advanced lesions without serious systemic toxicities.
Eighteen patients with locally advanced NSCLC under-
went BAI with CDDP at 50–100 mg/m2 as preoperative
induction chemotherapy.11 There were no serious BAI
therapy-related perioperative complications or postoper-
ative deaths. Survival was better when a complete resec-
tion was achieved after the induction BAI, especially in
patients with stage IIIB (T4) disease. In addition, three
patients underwent a carinal resection after induction
BAI for locally advanced NSCLC and demonstrated a
favourable prognosis.10 Induction BAI may contribute to
complete resection in tracheal malignancies.
Preoperative endoscopic treatments such as Nd:YAG
laser treatment, argon plasma coagulation, intraluminal
brachytherapy, and stenting, also play an important role
in the management of tracheal malignancies.5,21,22 These
bronchoscopic interventions before a tracheal resection
can improve the surgical results and increase the overall
success of these patients by providing both functional
improvement and precise staging.5,21,22 It is thought that
stenosis of the central airway of less than 60–80% due to
tracheal tumours does not prevent adequate ventilation,
clearance of secretions, correct evaluation of the site of
origin, or accurate extension of the distal margin of the
tumour.21 The primary indication for preoperative endo-
scopic treatment is more than 80% stenosis of the central
airway (Table 1, Figure 1). These patients also experienced
severe dyspnoea (Table 1). Several therapeutic options are
available when tracheal stenosis is relieved, depending on
the patient’s condition. Preoperative Nd:YAG laser abla-
tion improved the performance status in Case 2; sequen-
tial induction chemotherapy (BAI) could then be
performed, resulting in remarkable tumour reduction
without increasing postoperative complications. Further
studies of induction therapies for tracheal malignancies
may allow for the design of new therapeutic approaches
to control these diseases.
Rapid evaluations of the tumour (severity of stenosis,
location, length, and invasion status) and the possibility
for surgical resection is the most important strategy for
treating patients with stenosis of the central airway due
to tracheal tumours. Therefore, a complete resection, if
possible, provides the best potential benefit as well as
symptomatic relief for patients with tracheal tumours.
Furthermore, various options, including induction thera-
pies such as laser ablation and BAI, should be applied
according to the severity of tracheal stenosis and the
patient’s condition before surgical intervention.
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